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The mononuclear phagocyte system includes macrophages and dendritic cells (DCs), 
which are usually classified by morphology, phenotypical characteristics, and function. 
In the last decades, large research communities have gathered substantial knowledge 
on the roles of these cells in immune homeostasis and anti-infectious defense. However, 
these communities developed to a degree independent from each other, so that the 
nomenclature and functions of the numerous DC and macrophage subsets overlap, 
resulting in the present intense debate about the correct nomenclature. This controversy 
has also reached the field of experimental nephrology. At present, no mutually accepted 
way to distinguish renal DC and macrophages is available, so that many important roles 
in acute and chronic kidney disease have been ascribed to both DCs and macrophages. 
In this perspective article, we discuss the causes and consequences of the overlapping 
DC–macrophage classification systems, functional roles of DCs and macrophages, 
and the transferability of recent findings from other disciplines to the renal mononuclear 
phagocyte system from the nephrologist’s point of view.
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introduction
The current intense debate regarding the classification and nomenclature of dendritic cells (DCs) 
and macrophages has reached also the field of experimental nephrology. Numerous kidney diseases 
are immune mediated, such as the different forms of glomerulonephritis, and research over the last 
years has described important, yet overlapping roles of both cells types.
Macrophages and DCs are often considered distinct cell types based on their morphology and 
function. Macrophages were defined as large vacuolar cells that are highly phagocytic and modulate 
immune responses by production of immune mediators (1, 2), whereas DCs were characterized as 
stellate migratory cells that act as sentinels in non-lymphoid tissues and enter lymphoid tissues upon 
antigen encounter, present antigen and subsequently activate naïve T lymphocytes (3–5). Following 
these original descriptions, two research areas developed that more or less independently studied 
macrophages and DCs. This artificial separation has contributed to the emergence of different names 
for similar or the same cell types, thereby adding to the current confusion about their identity and 
function. In particular, advances in multi-color flow cytometry and gene-analyses enabled research-
ers to define many DC and macrophage subsets by the expression of a variety of surface molecules 
(6). As cell surface markers are easy to determine, they are widely used to classify mononuclear 
phagocytes, although they are rather unspecific and their expression patterns in the murine and 
human systems differ substantially.
Also in the kidney, surface markers and functional parameters have been used to propose several 
classification systems of mononuclear phagocytes. However, these systems overlap, comparable to 
the situation in other non-lymphoid organs, resulting in great uncertainty among experimental 
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nephrologists regarding the correct terminology. Here, we dis-
cuss the present state of our knowledge on renal mononuclear 
phagocytes in health and disease and problems resulting from the 
current nomenclature debate from a nephrologist point of view.
the Network of renal Dcs and 
Macrophages
The kidney parenchyma consists of the outer renal cortex and 
the inner renal medulla. Numerous individual functional units, 
the nephrons, span both compartments. The cortex contains 
glomeruli and proximal tubuli of the nephrons, which generate 
the primary urine. The medulla contains the loop of Henle, which 
generates a high osmolarity that is required for water reabsorption 
from the primary urine. The distal tubules end in collecting ducts 
through which the concentrated urine is transported into the 
renal pelvis and on through the ureters into the bladder. The space 
between the tubules is known as tubulointerstitium and contains 
blood vessels, fibroblasts, and numerous cells of the hematopoietic 
system that had been classified by pathologists as constituents of 
the reticuloendothelial system [reviewed in Ref. (7)].
Early immunological studies had classified the tubuloint-
erstitial mononuclear cells as macrophages due to their F4/80 
expression (8). During the early 1990s, several groups reported 
that these tubulointerstitial cells morphologically resembled DCs 
in humans and rodents (9–12), whereas cells with the typical 
morphology of macrophages were described to reside mainly in 
the kidney capsule, the intravasal lumina, and the pelvic wall of 
healthy kidneys (13). The use of CX3CR1-reporter mice and live 
cell imaging illustrated the intricate tubulointerstitial network of 
dendritiform processes that these cells use to constantly probe the 
environment, suggestive of DCs in action (14–16). The nomencla-
ture debate intensified when it became clear that the vast majority 
of renal mononuclear phagocytes possess the phenotype CD11c+ 
CD11b+ F4/80+ CX3CR1+ (17), which allows classification of both 
macrophages and DCs.
Notably, CX3CR1 exhibits relative organ specificity for renal 
mononuclear phagocytes: these cells were >50% reduced in the 
kidneys, but not in other organs (except the intestine) of CX3CR1-
deficient mice. This may be explained by the comparatively 
high renal expression of its ligand CX3CL1 (18). Notably, those 
CX3CR1+ phagocytes that co-express CD11c and exert DC func-
tionality were reduced even by more than 75% (18–20). This may 
result from an effect of CX3CR1 on CD11c expression, but this 
has yet to be shown. Interestingly, CX3CR1 regulated the numbers 
of the CD11c+ and the CD11c− renal mononuclear phagocytes 
by different mechanisms: it promoted homeostatic and inflam-
matory recruitment of the former, whereas it prevented in  situ 
proliferation of the latter under inflammatory conditions (20). 
Assuming that CD11c distinguishes renal DCs and macrophages, 
this difference would be consistent with recent reports that the 
number of tissue macrophages is regulated by local proliferation 
(21), whereas DC numbers are usually thought to be regulated by 
immigration and emigration (22).
The kidney also contains a minor subset of CD103+ DCs, 
which constitute <5% of all renal CD11c+ phagocytes and lack 
expression of CX3CR1, CD11b, and F4/80 (23), whose function 
currently is unclear. There are neither CD11b+ CD103+ DCs nor 
plasmacytoid DCs in the healthy kidney (24).
Functionality and Phenotype of renal 
Mononuclear Phagocytes
Researchers from both, the DC and the macrophage fields, have 
investigated kidney mononuclear phagocytes defined by cell 
surface markers in homeostasis and models of renal disease. 
Many important roles were shown in models of acute renal injury 
and in chronic immune-mediated kidney disease (Table 1), such 
as cytokine production or T cell-crosstalk in response to tissue 
injury or infection (17, 25–33). However, none of these functions 
is generally accepted to be exclusive for DCs or macrophages. 
Moreover, many nephrologists trained by the DC and macrophage 
communities still use CD11c and F4/80 to identify DCs and mac-
rophages, respectively (see Table 1), even though 70–90% of renal 
mononuclear phagocytes co-express these two markers (17), 
implying that they studied cellular subsets that largely overlap. 
Also, the tools used for loss-of-function studies cannot clearly 
discriminate between DCs and macrophages: CD11c–DTR mice 
are used to deplete kidney DCs, CD11b–DTR mice for depleting 
kidney macrophages but the expression of CD11c and CD11b 
on kidney mononuclear phagocytes is too heterogeneous for this 
black-and-white thinking (34). Clodronate liposomes are used for 
both purposes (35–38). All kidney mononuclear phagocytes are 
phagocytic (34) which might render them sensitive to clodronate 
liposomes.
The consequence of this overlap is well illustrated by two 
recent studies examining how CX3CR1 affects renal disease: both 
studies agreed that mononuclear phagocytes are substantially 
reduced in the kidneys of CX3CR1-deficient mice. However, one 
of them noted a higher susceptibility to renal candidiasis and 
attributed this to the loss of renal macrophages (19), while the 
other documented protection against glomerulonephritis and 
assigned this to the loss of renal DCs (18). A possible explana-
tion for this different classifications is that glomerulonephritis 
is driven mostly by phagocytes in the kidney cortex, in which 
glomeruli are located, whereas anti-infectious activity seem to 
be primarily due to phagocytes in the medulla, through which 
pathogens enter the kidney (18). Medullary phagocytes express 
significantly less CD11c than those in the cortex, which may bias 
their classification as DCs. The causes for these phenotypical and 
functional differences between medullary and cortical mononu-
clear phagocytes are unknown, but may result from differences in 
osmolarity, pH, and oxygen tension between these compartments, 
to which the mononuclear phagocytes may adapt. This would be 
in line with the current view that the tissue microenvironment 
dictates the organ-specific plasticity of macrophages (39, 40), and 
thus, perhaps also of renal mononuclear phagocytes.
re-Defining Kidney Mononuclear 
Phagocyte Nomenclature
The current definitions of renal DCs and macrophages are not 
mutually exclusive, so that renal mononuclear phagocytes may 
fulfill the definitions of both cell types simultaneously. This creates 
tABLe 1 | summary of the functions of mononuclear phagocyte subsets in renal diseases, which have been attributed to either renal Dc or 
macrophages, based on marker expression and/or disease attenuation or aggravation after cell depletion.
Disease Function and associated cell type classification of associated cell types
Acute renal injury Pro-inflammatory Pro-inflammatory
Ischemia/re-perfusion I. TNFa secretion DC
DC (26, 63, 64)
Macrophages (63, 64)
CD45+, CD11c+, MHCII+, CD11b+, CD16+, F4/80+, CD68+, CD4−, CD8−, CD205−, 
33D1−, CD169− CD204− (26)
II. Th activation Macrophages
Macrophages (63) Sensitive to liposomal dichloromethylene bisphosphonate (clodronate liposome) 
treatment, F4/80+ (63)
Sensitive to clodronate liposome treatment (64)
Anti-inflammatory Anti-inflammatory
I. Tissue regeneration DC
DC (33) Sensitive to clodronate liposome treatment, CD45+, MHCII+,CD11c+, F4/80+ (33)
Macrophages (67) Sensitive to clodronate liposome treatment, CD45+, MHCII+, CD11c+ (65)
II. Suppression of TNFa, IL-6, CXCL2, CCL2 
production by IRF4 upregulation
Sensitive to clodronate liposome treatment, CD11b+ (66)
DC (65) Macrophages
III. Prevention of renal failure Sensitive to clodronate liposome treatment, F4/80+ (67)
DC (66)
Unilateral ureter 
obstruction (UUO)
Pro-inflammatory Pro-inflammatory
I. Antigen presentation to CD4+ T cells DC
DC (27) CD11c+, T cell stimulatory, phagocytotic (27)
II. Accumulation of Th17 cells
   DC (28)
III. TNFa, TGFb production
   DC (28, 68)
   Macrophages (68)
IV. Tubular apoptosis
   DC (68)
   Macrophages (68)
V. Renal fibrosis
   DC (68, 69)
   Macrophages (68, 69)
CD45+, CD11c+, F4/80+, Ly6C− or CD45+, CD11c+, F4/80−, Ly6C−, sensitive to 
clodronate liposome treatment (28)
CD45+ CD11c+, F4/80+ (sensitive to clodronate liposomes) or F4/80− (not sensitive to 
clodronate liposomes) (68)
Macrophages
CD45+ F4/80+, CD11c−, sensitive to clodronate liposomes (68)
CD45+, CD11b+, Csfr1R-GFP+, CD11c−; depletion in CD11b–DTR mice (69)
Adriamycin nephropathy, 
cisplatin nephropathy, 
crystal nephropathy
Pro-inflammatory Pro-inflammatory
I. Aggravation of kidney injury in adriamycin-
induced nephropathy
DC
   Macrophages (25)
II. IL-1b secretion after inflammasome activation
   DC (29)
In vitro studies with bone marrow derived DC; renal CD45+, CD11c+ cells; sensitive to 
clodronate liposome depletion and diphtheria toxin in CD11c–DTRg mice (29)
Macrophages
CD45+, MHCII+, CD11c+, F4/80+, CD68+, CD204+, CD206+, CD103−; morphology, 
phagocytic capacity, ontogeny (25)
Anti-inflammatory Anti-inflammatory
I. Protective against cisplatin nephropathy, 
induction of IL-10
DC
DC (70) CD45+, MHCII+, CD11c+, CD11b+, F4/80+; morphology of GFP+ cells in CD11c–
DTRtg mice (70)
chronic renal disease Accumulating Accumulating
Glomerulonephritides I. Population changes during nephrotoxic 
nephritis
DC
DC (17) CD11c+, CD11b+, F4/80+; morphology, lysosomal content, phagocytic activity, 
microbicidal effector functions, expression of T cell costimulatory molecules, T cell 
activation (17)
Pro-inflammatory Pro-inflammatory
I. Crescent formation DC
Macrophages (71) MHCII+, CD11c+, F4/80− (72)
II. T cell infiltration and activation MHCII+, CD11c+ CD11b+, CD8−, B220−; depletion in CD11c–DTR mice; antigen 
presentation and T cell activation function (32)
DC (32, 72) Chemokine expression by CD11b+ CD11c+ DC was analyzed in lymphoid organs (73)
III. Chemokine expression Macrophages
DC (73) Sensitive to diphtheria toxin in CD11b-DTR mice, CD68+ (71)
(Continued)
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confusion, especially among those nephrologists that are more 
interested in disease relevance than in semantics. A recent 
proposal for a unified nomenclature has been based on cellular 
ontogeny: it proposes an initial division of mononuclear phago-
cytes into macrophages, monocytes and monocyte-derived cells 
and DCs (so-called “level 1 nomenclature”) (41). This classifica-
tion was based on the following facts: (1) most adult macrophages 
in tissues are successors of an embryonic precursor and main-
tained through self-renewal (42–46), (2) a common monocyte 
progenitor (cMoP) exists, which gives rise to monocytes (47), 
and (3) conventional DC (cDC) and plasmacytoid DC but not 
monocytes or macrophages arise from a common DC precursor 
(CDP) (48, 49). Thus, tissue-resident macrophages were classified 
by their origin from embryonic (yolk sac and fetal monocytes)-
derived erythro-myeloid progenitors (46, 50) and DC were 
classified as cells arising from hematopoietic stem cell-derived 
precursors, identified by genetic tracing via DNGR1 (CLEC9A) 
(51), which are distinct from monocyte/macrophage precursors. 
Finally, monocyte-derived cells differentiate from cMoP that can 
exert macrophage- or DC-like functions and express markers 
associated with either (41). This classification does not resolve 
the question whether monocyte-derived macrophages and 
monocyte-derived DCs are ontogenically distinct or whether one 
cell type displays high plasticity in different microenvironments. 
To include cell function, location, and morphology, the authors 
suggested to add a “level 2” nomenclature to the level 1 classifica-
tion (41).
While this nomenclature proposal might bring order into 
the ever increasing numbers DC and macrophage subsets, one 
major concern remains: without fate mapping tools, the origin of 
a phagocyte in a given tissue is usually not apparent, so that surro-
gate markers need to be used. Several markers for distinguishing 
phagocytes derived from different precursors are currently being 
discussed, but as we shall see below, they fail to discriminate renal 
DCs and macrophages.
One of these markers, CD64, alone or in combination with 
CCR2 or MerTK, has been reported to identify monocyte-derived 
macrophages and to be able to discriminate DC from non-DC in 
the intestine, the muscle and spleen (52–55), and the skin (56). 
DNGR1, when combined with genetic fate mapping technology, 
was shown to mark CDP and pre-DC (51), whereas Csf1r can 
be used for fate mapping of yolk sac derived (myb independ-
ent) tissue macrophages (46). In the kidney, most mononuclear 
phagocytes express CD64, low levels of CD11b and high levels 
of F4/80, which is not the case in other organs. However, 30% of 
CD64+ cells co-expressed the DNGR1-fate mapper, indicating 
that CD64 expression, despite the evidence for specificity in other 
organs, does not differentiate CDP-derived from monocyte-
derived cells in the kidney (51). Similarly, another fate mapping 
study that used Myb and PU.1 dependency for defining CD11bhi 
monocytes or macrophages and F4/80bright tissue macrophages 
derived by adult or embryonic hematopoiesis, respectively, 
found a dual origin in kidney macrophages as well (45). These 
findings highlight the difficulties when basing cellular classifica-
tion solely on ontogeny when ontogeny is based on surrogate 
markers. Furthermore, transferring ontogeny-based nomencla-
ture to human mononuclear phagocytes in tissue might prove 
impracticable.
A classification approach based on transcriptome analysis 
reported that CD11c+ MHC II+ cells in the kidney expressed a 
set of core DC markers characteristic of DCs in non-lymphoid 
tissues, that is absent from macrophages, including Zbtb64, Flt3, 
and CCR7 (57). These “core DC markers” had been defined by 
analyzing cDCs except the CD11b+ non-lymphoid tissue–DC, 
because of the great heterogeneity of CD11b+ cells. However, 
these constitute the vast majority of kidney mononuclear 
phagocytes.
Another classification approach is based on mononuclear 
phagocyte functionality. However, observed functions generally 
represent a snapshot of a cell within a specific context and time 
frame. Demonstrating that a phagocyte performs a given func-
tion under certain conditions at a certain time-point does not 
imply that this is a general feature of this cell. Furthermore, there 
is no clear demarcation between exclusive DC and macrophage 
functions. For example, macrophages phagocytose and degrade 
material. However, under certain conditions DCs do that too, 
albeit less efficiently [reviewed in Ref. (58)]. On the other hand, 
DCs classically activate naïve T cells, but macrophages can do 
Disease Function and associated cell type classification of associated cell types
Anti-inflammatory Anti-inflammatory
I. Induction of IL-10 secretion by CD4 T cells DC
DC (31) Morphology; MHCII+, CD11c+, CD11b+, sensitive to diphtheria toxin in CD11c-DTR 
mice (31)
II. Recruitment of regulatory CXCR6+ iNKT cells CD45+, CD11c+, depletion in CD11c-luciDTR mice (74)
DC (74)
infection Anti-infectious Anti-infectious
I. Bacterial clearance
   DC (18, 30)
II. Candida protection
   Macrophages (19)
III. Response to infectious stimuli, chemokine 
secretion, migration
   DC (75)
DC
MHCII+, CD45+, CD11c+, CD11b+, F4/80+, CX3CR1+ CD103−; depletion in  
CD11c–DTR mice (18, 30)
Enrichment by Flt3L administration, sorted by CD11c purification (75)
Macrophages
MHCII+, F4/80+, CD11b+, CD11clo; morphology (19)
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that too, albeit less efficiently (59, 60). Furthermore, the ability 
to stimulate T cells is difficult to determine on a single cell basis. 
A recent study differentiated renal mononuclear phagocytes 
into five phenotypically and functionally distinct populations 
(34). In that study, mononuclear phagocyte populations were 
differentiated by CD11c, CD11b, F4/80, CD103, CD14, CD16, 
and CD64 expression in juvenile and adult mice of different 
strains. Functional analyses and fate mapping studies were 
used for further characterization. In line with the complex-
ity of kidney mononuclear phagocyte subsets observed by 
others and us (17, 45, 51), the study revealed that all subsets 
expressed CD68 that is usually used to identify macrophages 
and that all subsets were phagocytic but showed differences in 
their antigen presentation capacity. Fate mapping experiments 
identified one population with a dual origin, two populations 
that were closely related to monocytes, whereas the remaining 
two were not. Notably, the largest population not only showed 
the phenotypical and functional characteristics of reparative 
macrophages (M2) but also had significant antigen presenta-
tion function and most likely emigrated from the kidney under 
inflammatory conditions. Additionally, this population dif-
fered significantly between mouse strains, which might explain 
immunological differences between those strains. The authors 
concluded that functions are more related to context than 
separate lineage and suggested their marker combination as an 
unbiased approach to identify kidney mononuclear phagocyte 
populations (34). These findings are consistent with recent 
concepts that macrophage fine differentiation is shaped by the 
tissue microenvironment (39, 40).
concluding remarks
As a consequence of the separate development of the DC and 
macrophage research communities, the functional and pheno-
typic definitions of these cell types overlap substantially. Thus, 
scientists from both communities often study the same cells, 
perhaps unaware of, or ignoring progress and concepts in the 
other field. The false assumption that classifying a mononuclear 
phagocyte as a macrophage implies that it is not a DC, and 
vice  versa, hampers communication between researchers from 
both fields. Some studies have focused on arguing about subsets 
and semantics (61), perhaps hoping to “claim territory” for their 
own communities. This may result in highly citable or controver-
sial publications, but it does not advance our understanding of 
mononuclear phagocytes, neither in the kidney nor elsewhere.
An overlapping classification system, such as the existing one, 
is certainly not desirable. An improvement is needed. It is unreal-
istic to assume that either the DC or the macrophage community 
will accept the nomenclature of the other field. Drawing a line that 
segregates mononuclear phagocytes into DCs or macrophages 
will unlikely be acceptable to both fields. Furthermore, there are 
currently no unambiguous discriminatory parameters; for any 
new parameters introduced, exceptions are reported quickly, 
such as for CD64 and DNGR1-fate tracking in the kidney. Still, 
an improved classification system is needed. How can we reach 
a consensus?
First, the purpose of the revised classification system needs to 
be defined. Clinicians are interested in cellular entities that are 
useful for diagnostic or therapeutic purposes and translational 
immunologists often study the functions of cellular subsets. 
Basic immunologists may favor ontogeny, which is biologically 
the cleanest and most logical approach. However, mononuclear 
phagocytes adapt their gene enhancer landscape according to the 
tissue of residence independently of the precursor they originated 
from (39), an ontogeny-based nomenclature may lead to different 
cell types with similar functionality, or to cells of the same name 
with different functionality depending on the organ they reside 
in. Moreover, the origin of a mononuclear phagocyte in a given 
tissue is not obviously apparent, because unique discriminatory 
parameters are missing. Thus, ontogeny, although theoretically 
logical, will be difficult to use for routine research. At the end 
of the day, a classification system needs to be convenient and 
feasible, or it will not be used.
The late Ralph Steinman remarked “The DC is a functional 
state” (personal communication). Indeed, at the age of single 
cell transcriptomics, it becomes clear that several transcriptional 
programs may run simultaneously in individual mononuclear 
phagocytes, and confer a spectrum of functionalities that are 
more or less consistent with the current concepts of a DC, of a 
macrophage, or both. Current technical advances will undoubt-
edly allow distinguishing far more functional states of mono-
nuclear phagocytes. In the field of renal immunology, experts 
coming from the DC and macrophage communities have jointly 
suggested avoiding the DC–macrophage controversy altogether 
by referring to mononuclear phagocytes (preferentially using a 
“catchier” name for these cells), with different degrees of DC- or 
macrophage-, or other functionalities (62). It remains to be seen 
whether basic immunologists and scientists studying mononu-
clear phagocytes in other organs feel that this is useful or not.
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